| abstract |
An optical method for detecting Alzheimer's disease is provided. The subject of the present invention is a non-invasive optical imaging method for monitoring early pathological events specific to Alzheimer's disease (AD), such as the occurrence, amount and location of amyloid plaques. About. The ability to monitor such events provides a basis for, among other things, AD diagnosis, prognosis prediction and evaluation of potential treatments. Furthermore, the present subject matter introduces a novel method for treating AD and retinal diseases associated with AD. Aβ plaque detection in the living brain is extremely limited, especially at high resolution; thus, the present invention provides an alternative to brain-derived tissue that can be imaged directly, iteratively and non-invasively. As based on research that focuses on the eye. [Selection] Figure 1 |